Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination pharmacotherapy for neuropathic pain
ISRCTN04803491Phase 4Completed
- Sponsor
- Queen's University
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Neuralgia comparing Morphine + nortriptyline, Morphine and Nortriptyline (3 arms). Primary endpoint: Daily pain intensity. Started Nov 2009; status: completed.
02
Drugs
morphinenortriptyline
03
Conditions
Neuralgia
Beyond the preview
Go deeper on ISRCTN04803491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN04803491.